Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis

BACKGROUND: In patients with newly diagnosed glioblastoma, rapid early progression (REP) refers to tumor regrowth between surgery and postoperative chemoradiotherapy. This systematic review and meta-analysis appraised previously published data on REP to better characterize and understand it. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Waqar, Mueez, Roncaroli, Federico, Lehrer, Eric J, Palmer, Joshua D, Villanueva-Meyer, Javier, Braunstein, Steve, Hall, Emma, Aznar, Marianne, De Witt Hamer, Philip C, D’Urso, Pietro I, Trifiletti, Daniel, Quiñones-Hinojosa, Alfredo, Wesseling, Pieter, Borst, Gerben R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234755/
https://www.ncbi.nlm.nih.gov/pubmed/35769410
http://dx.doi.org/10.1093/noajnl/vdac075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234755/
https://www.ncbi.nlm.nih.gov/pubmed/35769410
http://dx.doi.org/10.1093/noajnl/vdac075

Ejemplares similares